Clinical trials
6 active studies led by Kriya Therapeutics, Inc., of 6 in all
Source: ClinicalTrials.gov, Studies with Kriya Therapeutics, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 4Markets in public records
- 0Regions & countries
- 6Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Kriya Therapeutics, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Kriya Therapeutics, Inc.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Kriya Therapeutics, Inc. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Kriya Therapeutics, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Kriya Therapeutics, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Kriya Therapeutics, Inc. is in.
From our blog
Stories on the topics Kriya Therapeutics, Inc. works in.
Health Data Exchange: Why EDI Matters for Payers and Providers
Behind every insurance claim is a standard electronic message. The CAQH Index says $20 billion a year could…
Read
Wound Care: Advanced Dressings for Faster Healing
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read
Patient Support Programmes: Helping Patients Stay on Treatment
WHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient…
ReadSearch all reports for Kriya Therapeutics, Inc. All companies